Blood Vessels News and Research

RSS

Tight glucose control lowers CVD by about 50 percent in diabetes

A significantly lower risk of heart disease can now be added to the list of proven long-term benefits of tight glucose control in people with type 1 diabetes.

12 Jun 2005

Ruboxistaurin shows favorable effects on kidney damage and function in people with type 2 diabetes and nephropathy

Eli Lilly and Company today announced encouraging results from a one-year pilot study examining the effect of ruboxistaurin mesylate in persons with type 2 diabetes and kidney disease (also known as "diabetic nephropathy").

12 Jun 2005

Link between PKC enzyme and kidney disease in diabetes confirmed

Researchers at Joslin Diabetes Center have investigated PKC-beta - a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes - for more than two decades.

12 Jun 2005

Link between hyperglycemia (high blood glucose), overexpression of PKC-beta 2 and kidney disease

Scientists at Joslin Diabetes Center have investigated PKC-beta -- a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes -- for more than two decades.

10 Jun 2005

Study sheds light on endometriosis pain

Women with endometriosis often have several types of chronic pain conditions because their abnormal growths develop a nerve supply that communicates with the brain, new research suggests.

10 Jun 2005

Patients with cancer of the esophagus benefit from new technique developed by OHSU surgeons

Surgeons at the Oregon Health & Science University Digestive Health Center have developed a new technique that makes feasible and safe a potentially lifesaving and noninvasive surgical procedure known as laparoscopic esophagectomy.

9 Jun 2005

Designed drug for combined hormone and chemotherapy treatment

The search for new drugs to fight cancer remains at the top of the to do list for pharmaceutical researchers. A recent variation is polymer chemotherapy agents, drugs that have been attached to a "backbone" of long chain molecules.

9 Jun 2005

Atrial fibrillation may soon have an effective treatment

In laboratory tests in dogs, cardiac researchers at Washington University School of Medicine in St. Louis have found that treatment with anti-inflammatory drugs after heart surgery may lessen or prevent atrial fibrillation. They report their findings in the June 7 issue of Circulation.

8 Jun 2005

Arena Pharmaceuticals issued new patent

Arena Pharmaceuticals has announced that it was issued U.S. patent number 6,902,902, entitled "Human G Protein-Coupled Receptors and Modulators Thereof for the Treatment of Metabolic-Related Disorders," by the U.S. Patent Office.

8 Jun 2005

Chocolate and exercise on the anti-obesity treadmill

Researchers at the University of South Australia are seeking volunteers for a new study into the potential health benefits of combining regular exercise with daily chocolate consumption.

6 Jun 2005

Discovery will lead to more effective treatments for pulmonary arterial hypertension

A University of Alberta research team has discovered important new information they hope will lead to more effective treatments for pulmonary arterial hypertension (PAH)--a deadly form of high blood pressure in the pulmonary arteries caused by uncontrolled cell growth.

5 Jun 2005

Medication errors dramatically reduced in patients with kidney disease

A first of its kind study has shown a dramatic reduction in medication errors in patients with chronic kidney disease when Kaiser Permanente Colorado researchers teamed with pharmacists to use a computerized system to electronically screen prescriptions for unsafe medication orders.

3 Jun 2005

Early surgical removal of the spleen combined with antiangiogenic cancer therapy may halt the progression of leukemia

The research, published today in Blood, is the first to show the combination of two factors secreted from the environment of the spleen is important in the promotion of leukemia.

1 Jun 2005

Triple approach is promising against cancer cells

A trimodal treatment strategy combining chemotherapy, radiation therapy, and a protein kinase inhibitor is much more effective against cancer cells than any combination of only two treatment methods.

1 Jun 2005

Diabetics more sensitive to cardiovascular effects from air pollution

People with diabetes may be at higher risk for cardiovascular problems when air pollution levels are higher, according to a new study of Boston-area residents. The ability of the blood vessels to control blood flow was impaired in adults with diabetes on days with elevated levels of particles from traffic and coal-burning power plants.

31 May 2005

Long-haul flights, length of time under anesthesia increase risk of developing blood clots

The prolonged immobility of flight passengers during long-haul air travel increases the risk of developing blood clots, which could prove fatal especially to people whose travel occurs just prior to major surgery, medical researchers report in the current issue of Mayo Clinic Proceedings.

31 May 2005

New approach to inhibiting blood vessel growth or angiogenesis

A manmade protein with a tail of amino acids delivered to target cells can dramatically reduce blood vessel growth that obstructs vision or feeds a tumor, researchers have found.

31 May 2005

Targepeutics issued new U.S patent

Targepeutics has announced the issuance of U.S. Patent No. 6,884,603 for its genetically modified, mutated Interleukin 13 (IL-13) technology platform for the treatment of malignant glioma, a brain tumor (17,500 people annually; $200 million annual market).

31 May 2005

Shock wave therapy shows remarkable results in wound healing and curing myocardial diseases

Effective, non-invasive and practically without side effects - extracorporeal shock wave therapy has demonstrated impressive results not only in orthopedics and traumatology, but also in treating fresh and chronic wounds as well as circulatory disorders of the myocardial muscle.

31 May 2005

Fluorescence device to diagnose atherosclerosis and tumors

In a presentation at the Conference on Lasers and Electro-Optics (CLEO), researchers from Cedars-Sinai Medical Center's Biophotonics Research and Technology Development Laboratory described recent progress on a device that stimulates, collects and measures light emissions from body tissues to diagnose critical atherosclerotic plaques (vulnerable plaques) and aggressive brain tumors.

29 May 2005